RESPONSE OF DRUG AMALGAMATION THROUGH COPPER NANOPARTICLES AS MAJESTIC HELPERS TO HALT THE THIRD WAVE OF SARS-COV-2, A REVIEW

NAEEM, ASMA and SHAHEEN, FAIQA and SHAHZADI, ANILA and ARSALAN, HAFIZ MUHAMMAD and SARWAR, NAILA and HABIBA, UME and FARHEEN, NEELAM and HEWADMAL, HEWAD and ARSHAD, SHAFIA and ARIF, AMINA (2022) RESPONSE OF DRUG AMALGAMATION THROUGH COPPER NANOPARTICLES AS MAJESTIC HELPERS TO HALT THE THIRD WAVE OF SARS-COV-2, A REVIEW. PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY, 23 (21-22). pp. 1-13. ISSN 0972-2025

Full text not available from this repository.

Abstract

The contemporary contagious ailment is caused by one of the deadliest coronaviruses, the SARS-COV-2. This novel zoonotic entity leads to multi-organ failure and an escalating threat and turbulence all over the world. Albeit a lot of work has been done to beat this virus, it is still radiating consistently. A colossal number of antiviral drugs has been tested to overcome the current pandemic but no promising remedy. A new approach to employ drug amalgamation such as remdesivir with hydroxychloroquine and losartan would better eradicate this outbreak. For this purpose, copper nanoparticles (extracted from a Prophetic, miraculous herb Nigella sativa) would serve as excellent transporters of such kinds of drug composites. In this review, the several possible therapies available across the world will be discussed in addition to the existing evidence for each of them. This new insight would be beneficial to fight against the latest rife.

Item Type: Article
Subjects: STM Open Academic > Biological Science
Depositing User: Unnamed user with email admin@eprint.stmopenacademic.com
Date Deposited: 02 Dec 2023 05:52
Last Modified: 02 Dec 2023 05:52
URI: http://publish.sub7journal.com/id/eprint/1703

Actions (login required)

View Item
View Item